| Corrigendum: Multiple-laboratory comparison of microarray platforms RA Irizarry, D Warren, F Spencer, IF Kim, S Biswal, BC Frank, ... Nature Methods 2 (6), 477-477, 2005 | 1070* | 2005 |
| Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-κB-responsive genes in cervical keratinocytes M Nees, JM Geoghegan, T Hyman, S Frank, L Miller, CD Woodworth Journal of virology 75 (9), 4283-4296, 2001 | 495 | 2001 |
| Acquired copy number alterations in adult acute myeloid leukemia genomes MJ Walter, JE Payton, RE Ries, WD Shannon, H Deshmukh, Y Zhao, ... Proceedings of the National Academy of Sciences 106 (31), 12950-12955, 2009 | 294 | 2009 |
| Discovery of a previously unrecognized microdeletion syndrome of 16p11. 2–p12. 2 BC Ballif, SA Hornor, E Jenkins, S Madan-Khetarpal, U Surti, KE Jackson, ... Nature genetics 39 (9), 1071-1073, 2007 | 243 | 2007 |
| Nuclear factor-κB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma A Loercher, TL Lee, JL Ricker, A Howard, J Geoghegen, Z Chen, ... Cancer research 64 (18), 6511-6523, 2004 | 241 | 2004 |
| Nuclear factor-κB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma A Loercher, TL Lee, JL Ricker, A Howard, J Geoghegen, Z Chen, ... Cancer research 64 (18), 6511-6523, 2004 | 241 | 2004 |
| Nuclear factor-κB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma A Loercher, TL Lee, JL Ricker, A Howard, J Geoghegen, Z Chen, ... Cancer research 64 (18), 6511-6523, 2004 | 241 | 2004 |
| Mutations in the mammalian target of rapamycin pathway regulators NPRL2 and NPRL3 cause focal epilepsy MG Ricos, BL Hodgson, T Pippucci, A Saidin, YS Ong, SE Heron, ... Annals of neurology 79 (1), 120-131, 2016 | 209 | 2016 |
| Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease S Branford, P Wang, DT Yeung, D Thomson, A Purins, C Wadham, ... Blood, The Journal of the American Society of Hematology 132 (9), 948-961, 2018 | 181 | 2018 |
| Three microarray platforms: an analysis of their concordance in profiling gene expression D Petersen, GVR Chandramouli, J Geoghegan, J Hilburn, J Paarlberg, ... Bmc Genomics 6, 1-14, 2005 | 149 | 2005 |
| Detection of clinically relevant copy number variants with whole‐exome sequencing J de Ligt, PM Boone, R Pfundt, LELM Vissers, T Richmond, J Geoghegan, ... Human mutation 34 (10), 1439-1448, 2013 | 129 | 2013 |
| Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-β2 in cervical keratinocytes M Nees, JM Geoghegan, P Munson, V Prabhu, Y Liu, E Androphy, ... Cancer research 60 (15), 4289-4298, 2000 | 129 | 2000 |
| HENMT1 and piRNA stability are required for adult male germ cell transposon repression and to define the spermatogenic program in the mouse SL Lim, ZP Qu, RD Kortschak, DM Lawrence, J Geoghegan, ... PLoS genetics 11 (10), e1005620, 2015 | 113 | 2015 |
| Metastatic squamous cell carcinoma cells that overexpress c-Met exhibit enhanced angiogenesis factor expression, scattering and metastasis in response to hepatocyte growth factor G Dong, TL Lee, NT Yeh, J Geoghegan, CV Waes, Z Chen Oncogene 23 (37), 6199-6208, 2004 | 71 | 2004 |
| The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution D Singhal, LYA Wee, MM Kutyna, R Chhetri, J Geoghegan, AW Schreiber, ... Leukemia 33 (12), 2842-2853, 2019 | 48 | 2019 |
| Towards routine implementation of liquid biopsies in cancer management: it is always too early, until suddenly it is too late MJ IJzerman, J de Boer, A Azad, K Degeling, J Geoghegan, C Hewitt, ... Diagnostics 11 (1), 103, 2021 | 43 | 2021 |
| DNA barcoding reveals habitual clonal dominance of myeloma plasma cells in the bone marrow microenvironment DR Hewett, K Vandyke, DM Lawrence, N Friend, JE Noll, JM Geoghegan, ... Neoplasia 19 (12), 972-981, 2017 | 24 | 2017 |
| Aberrant Splicing of SDHC in Families With Unexplained Succinate Dehydrogenase-Deficient Paragangliomas SMC De Sousa, J Toubia, TSE Hardy, J Feng, P Wang, AW Schreiber, ... Journal of the Endocrine Society 4 (12), bvaa071, 2020 | 8 | 2020 |
| The global transcriptomic signature in sinonasal tissues reveals roles for tissue type and chronic rhinosinusitis disease phenotype. A Bassiouni, J Ou, A Schreiber, J Geoghegan, A Tsykin, AJ Psaltis, ... Rhinology 58 (3), 273-283, 2020 | 8 | 2020 |
| Delayed diagnosis leading to accelerated-phase chronic eosinophilic leukemia due to a cytogenetically cryptic, imatinib-responsive TNIP1–PDFGRB fusion gene DM Ross, HK Altamura, CN Hahn, M Nicola, AL Yeoman, MR Holloway, ... Leukemia 30 (6), 1402-1405, 2016 | 8 | 2016 |
